Boehringer Ingelheim launches AI centre in London
Summary
The new site will focus on the use of AI models for purposes including the discovery and development of targeted medicines for patients with unmet medical needs.
Description
The new site will focus on the use of AI models for purposes including the discovery and development of targeted medicines for patients with unmet medical needs.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source